Name | SULFAPHENAZOLE |
Synonyms | Orisul Orisulf Paidazolo SULFAPHENAZOLE LABOTEST-BB LT00772280 N1-(1-Phenylpyrazol-5-yl)sulfanilamide n'-(1-phenylpyrazol-5-yl)sulfanilamide n(sup1)-(1-phenylpyrazol-5-yl)sulfanilamide 4-AMINO-N-(1-PHENYL-1H-PYRAZOL-5-YL)BENZENESULFONAMIDE |
CAS | 526-08-9 |
EINECS | 208-384-3 |
Molecular Formula | C15H14N4O2S |
Molar Mass | 314.36 |
Density | 1.39 |
Melting Point | 179-183 °C |
Boling Point | 541.9±56.0 °C(Predicted) |
Solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) |
Appearance | Solid |
Color | white to light yellow |
pKa | pKa 5.71(H2O t = 25 I = 0.05) (Uncertain) |
Storage Condition | 2-8°C |
Refractive Index | 1.6440 (estimate) |
Physical and Chemical Properties | Bioactive Sulfaphenazole is a specific inhibitor of CYP2C9, which inhibits CYP2C9-mediated linoleic acid atherosclerosis and pro-inflammatory effects (increasing oxidative stress and activation of AP-1) and is used as an antibacterial agent. |
Use | Use Sulfadibenzazole is a specific inhibitor of CYP2C9, which can block CYP2C9-mediated linoleic acid-induced atherosclerosis and pro-inflammatory effects (increasing oxidative stress and activating AP-1). Play the role of antibacterial and antibacterial. Sulfamepyrazole was used as a positive control to inhibit cytochrome P450 2C9 (cyp2c9) to quantify the inhibitory effect of Rhodiola rosea. It was also used as a cytochrome P450 2C9 (cyp2c9) inhibitor in endothelial cells and microsomal preparations. |
Safety Description | 24/25 - Avoid contact with skin and eyes. |
WGK Germany | 2 |
RTECS | DA9520000 |
HS Code | 29339900 |
Toxicity | LD50 orally in mice: 5800 mg/kg (Seki) |
Reference Show more | 1. Wang Chengyu, Li Dengke, Quan Zhengyang, Hu Ying also, Sun Zhenxiao. Study on hepatotoxicity and related components of Polygonum multiflorum based on cytochrome oxidase CYP2D6 [J]. Pharmacovigilance in China, 2021,18(03):220-227 239. 2. Chen Rui, Zhou Wei, Zhang Li, Zhu Gaogao, Huang Jing, Tang Lei. In vitro inhibition of five common Cytochrome P_(450) enzymes in human liver microsomes by bevacizumab acid A [J]. China Pharmacy, 2021,32(02):195-200. 3. Hu et al Ying-huan [IF = 3.5]. "Inhibition of CYP3A4 senses aloe-emodin induced hepatocyte injury." Toxicol In Vitro. 2021 Dec;:105276 |